Emerging Topics in Cognitive Impairment: from Prevention to Intervention

Wauwatosa, WI US
March 29, 2014
     Alzheimer disease and other dementias are the result of a process which starts years before the onset of cognitive loss.  New types of dementias are now identified and midlife risk factors for later onset of dementia such as obesity, trauma or depression have been identified. While the advancement of pharmacological disease modifying intervention have been disappointing in the last few years, the identification of people at risk is now possible with genetic and radiological markers. This symposium will address the potential benefits of early diagnosis and discuss dementia prevention.
     Because there is limited pharmacological treatment at present, diagnosing dementia is of limited clinical interest in the medical community. However the introduction of biomarkers with CSF analysis and radiological techniques allow us to make an accurate diagnosis and identify among the healthy population those at future risk for dementia. Therefore prevention of dementia must be discussed with patients and healthy elderly, introducing healthy life style habits and choices, hopefully reaching the success attained with the prevention of stroke and cardiac disease. 
     As biomarkers are developed for the diagnosis of memory loss and prevention strategies are tested, the clinician still is confronted with the management of the patient with dementia. This symposium will target emerging topics in the psychosocial management of people with dementia such as driving and behavioral management  as well as current status of cognitive pharmacology including deep brain stimulation for Alzheimer disease.


ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.5 hours of participation for continuing education for allied health professionals.

Target Audience


Primary Care Physicians





Social Workers

Learning Objectives

  • Understand the role of biomarkers for dementia such as amyloid PET imaging and CSF markers in research and clinical practice
  • Assess less common forms of dementia and the implications of vascular disease and trauma to the development of dementia
  • Identify steps to take in managing driving in the person with dementia as well as have a method in the management of the common behavioral manifestations in dementia
Additional information


Vicki Conte
Phone Number: 
+1 (414) 805-8326
Course summary
Available credit: 
  • 4.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
03/29/2014 - 7:45am
Event ends: 
03/29/2014 - 2:00pm
The Medical College of Wisconsin
8701 Watertown Plank Road
The Alumni Center, Parking is available directly across the street from the main entrance
Wauwatosa, WI 53226
United States

Antuono Piero , MD - Course Director

The Medical College of Wisconsin Faculty
Diane Book, MD Associate Professor of Neurology, Medical Director FMLH-MCW Stroke Program
Malgorzata Franczak, MD  Associate Professor of Neurology, Zablocki VA Medical Center                         
Joseph Goveas, MD  Associate Professor of Psychiatry, Training Director Gero-psychiatry Fellowship Program
Robert Hellman, MD Associate Professor of Radiology, Director, Div. of Nuclear Medicine, Zablocki VA Medical Center
Jessica Keuster, MD  Assistant Professor, Dept. of Medicine, Zablocki VA Medical Cener, Div. of Geriatrics
Michael McCrea, PhD Professor of Neurology & Neurosurgery

Guest Faculty
Dane Cook, PhD, Associate Professor of Kinesiology, University of Wisconsin, Madison, WI

J. Cara Pendergrass, PhD, Vice President, Clinical Operations, Clinical Neuropsychologist, Boston, MA


All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:

J. Cara Pendergrass, PhD      Clintara, LLC       Employment
In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.


Available Credit

  • 4.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.50 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.